Ubs Group Ag Viatris Inc Put Options Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $1.26 Million - $1.5 Million	125,200 New	125,200 $1.33 Million
Q3 2023 Nov 09, 2023	BUY	$9.59 - $11.35 $863,100 - $1.02 Million	90,000 Added 23.85%	467,300 $4.61 Million
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $2.66 Million - $3.03 Million	-294,800 Reduced 43.86%	377,300 $3.77 Million
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $5.67 Million - $7.56 Million	-616,800 Reduced 47.85%	672,100 $6.47 Million
Q4 2022 Feb 08, 2023	BUY	$8.72 - $11.56 $1.07 Million - $1.42 Million	123,000 Added 10.55%	1,288,900 $14.3 Million
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $5.15 Million - $6.76 Million	607,300 Added 108.72%	1,165,900 $9.93 Million
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $2.57 Million - $3.17 Million	258,600 Added 86.2%	558,600 $5.85 Million
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $9.81 Million - $15.4 Million	-1,000,034 Reduced 76.92%	300,000 $3.26 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $7.87 Million - $9.55 Million	-650,612 Reduced 33.35%	1,300,034 $17.6 Million
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $2.66 Million - $3.03 Million	-200,577 Reduced 9.32%	1,950,646 $26.4 Million
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $4.59 Million - $5.72 Million	-353,884 Reduced 14.13%	2,151,223 $30.7 Million
Q1 2021 May 12, 2021	BUY	$13.59 - $18.54 $31.6 Million - $43.1 Million	2,322,997 Added 1275.6%	2,505,107 $35 Million
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $2.6 Million - $3.41 Million	182,110 New	182,110 $3.41 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.